Clinical Trial Update: Response to Immunotherapy in MMR-deficient Localized Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating an immunotherapy in patients with mismatch repair-deficient localized colon cancer reports results. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Camilla Qvortrup | Conditions: Colon Cancer | Phase 2 | Status: COMPLETED